Published October 31, 2024
| Version v1
Dataset
Restricted
Revised "iRR6" model in intermediate-1 risk myelofibrosis patients treated with ruxolitinib
Authors/Creators
- 1. IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy